SCHEMBL14917574

SCHEMBL14917574

CCC1=NCCO1.CCC1=NCCO1

nearest known ligand 0.47

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 4/20 0.33
ADRA2B P18089 4/20 0.33
ADRA2C P18825 4/20 0.33
ADRA1A P35348 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25266 1.00
SCHEMBL6683456 0.97
Propane SCHEMBL28148423 0.97 ADRA2A (0.32) ADRA2AADRA2BADRA2CADRA1ASMN1; SMN2
Ammonia Solution, Strong SCHEMBL27742777 0.97 ADRA2A (0.32) ADRA2AADRA2BADRA2CADRA1ASMN1; SMN2
SCHEMBL3919995 0.97 ADRA2A (0.32) ADRA2AADRA2BADRA2CADRA1ASMN1; SMN2
Oxirane SCHEMBL28312924 0.95 ADRA2A (0.34) ADRA2AADRA2BADRA2CADRA1A
Alcohol SCHEMBL28228159 0.93 ADRA2A (0.30) ADRA2AADRA2BADRA2CADRA1A
SCHEMBL10755796 0.87
Phosphoric Acid SCHEMBL10750839 0.87
Sulfuric Acid SCHEMBL10754641 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11814766-B2 Systems and methods for automated manufacturing of flexible goods and related technologies Sewbo, Inc. (US) 2023-11-14 US claimed
EP-3565923-B1 METHODS FOR AUTOMATED MANUFACTURING OF FLEXIBLE GOODS SEWBO INC (US) 2023-10-25 EP claimed
US-20200165762-A1 SYSTEMS AND METHODS FOR AUTOMATED MANUFACTURING OF FLEXIBLE GOODS AND RELATED TECHNOLOGIES Sewbo, Inc. 2020-05-28 US claimed
EP-3565923-A1 SYSTEMS AND METHODS FOR AUTOMATED MANUFACTURING OF FLEXIBLE GOODS AND RELATED TECHNOLOGIES Sewbo, Inc. (US) 2019-11-13 EP claimed
EP-3303470-B1 PERFLUOROELASTOMERIC COMPOSITIONS COMPRISING OXAZOLES 3M INNOVATIVE PROPERTIES CO (US) 2019-09-18 EP disclosed
US-9333269-B2 Polyplex gene delivery vectors THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2016-05-10 US disclosed
US-20130115699-A1 POLYPLEX GENE DELIVERY VECTORS THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130115699-A1 POLYPLEX GENE DELIVERY VECTORS PCNP, ANP32A, ANP32B ADRA2A 4710/4885ADRA2B 4461/4885ADRA2C 4513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.